Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro
Authors
Keywords
MiR-221, Hepatocellular carcinoma (HCC), Cell growth, Cell cycle, Apoptosis, Caspase
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-01-16
DOI
10.1186/1471-2407-13-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- microRNA Involvement in Hepatocellular Carcinoma
- (2012) Massimo Negrini et al. Anti-Cancer Agents in Medicinal Chemistry
- Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
- (2012) Gang Chen et al. BMC Medicine
- MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration
- (2012) Qinggong Yuan et al. HEPATOLOGY
- MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma
- (2012) Claudia Augello et al. LIVER INTERNATIONAL
- Morphometric analysis of hepatocellular nodular lesions in HCV cirrhosis
- (2012) Maurizio Vertemati et al. PATHOLOGY RESEARCH AND PRACTICE
- Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance
- (2011) Jipeng Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells
- (2011) Gang Chen et al. BIOLOGICAL PROCEDURES ONLINE
- miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
- (2011) J.-K. Park et al. CANCER RESEARCH
- Novel insights into the molecular mechanisms of α-fetoprotein expression and malignant phenotypes of hepatocellular carcinoma
- (2011) Zhiqing Hu et al. Cellular & Molecular Immunology
- The Role of Oncogenic Viruses in the Pathogenesis of Hepatocellular Carcinoma
- (2011) Romy Zemel et al. Clinics in Liver Disease
- Molecular Pathogenesis of Hepatocellular Carcinoma: Altering Transforming Growth Factor-β Signaling in Hepatocarcinogenesis
- (2011) Ken Yamazaki et al. DIGESTIVE DISEASES
- MicroRNA-221 regulates FAS-induced fulminant liver failure
- (2011) Amar Deep Sharma et al. HEPATOLOGY
- The functional role of long non-coding RNA in human carcinomas
- (2011) Ewan A Gibb et al. Molecular Cancer
- Hepatocellular Carcinoma in 2011 and Beyond: From the Pathogenesis to Molecular Targeted Therapy
- (2011) Masatoshi Kudo ONCOLOGY
- MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria
- (2011) Fumiaki Sato et al. PLoS One
- miR-221/222 suppression protects against endoplasmic reticulum stress-induced apoptosis via p27Kip1- and MEK/ERK-mediated cell cycle regulation
- (2010) Rongyang Dai et al. BIOLOGICAL CHEMISTRY
- TNM seventh edition: What's new, what's changed
- (2010) Leslie H Sobin et al. CANCER
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma
- (2010) Lang Hu et al. Hepatology International
- Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma
- (2010) Xinhui Fu et al. MOLECULAR BIOLOGY REPORTS
- Serum microRNAs as non-invasive biomarkers for cancer
- (2010) Jan C Brase et al. Molecular Cancer
- microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
- (2010) Julja Burchard et al. Molecular Systems Biology
- Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma
- (2010) Shu Diao et al. PROTEOMICS
- Quantification of epidermal growth factor receptor T790M mutant transcripts in lung cancer cells by real-time reverse transcriptase–quantitative polymerase chain reaction
- (2009) Gang Chen et al. ANALYTICAL BIOCHEMISTRY
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
- (2009) L. Gramantieri et al. CLINICAL CANCER RESEARCH
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated
- (2009) Xiao-Hui Huang et al. HEPATOLOGY RESEARCH
- Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
- (2009) Melanie B. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
- (2009) Sandrine Faivre et al. LANCET ONCOLOGY
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma on Cirrhosis: State of the Art and Future Perspectives
- (2009) Antonio Giorgio Recent Patents on Anti-Cancer Drug Discovery
- MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL
- (2009) Qiang Lu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Molecular Mechanisms Underlying Hepatocellular Carcinoma
- (2009) Philippe Merle et al. Viruses-Basel
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease
- (2008) N. T. Zinkin et al. CLINICAL CANCER RESEARCH
- MicroRNA-223 Is Commonly Repressed in Hepatocellular Carcinoma and Potentiates Expression of Stathmin1
- (2008) Queenie W.–L. Wong et al. GASTROENTEROLOGY
- Molecular mechanisms of hepatocellular carcinoma
- (2008) Rajagopal N. Aravalli et al. HEPATOLOGY
- MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma
- (2008) Shuai Li et al. HEPATOLOGY
- Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma
- (2008) Shunsuke Ura et al. HEPATOLOGY
- Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target
- (2008) Yu Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA involvement in hepatocellular carcinoma
- (2008) Laura Gramantieri et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
- (2008) F Fornari et al. ONCOGENE
- Expression of Heparanase in Hepatocellular Carcinoma Has Prognostic Significance: A Tissue Microarray Study
- (2008) Gang Chen et al. ONCOLOGY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now